Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

Keaney JF Jr, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, Loscalzo J.

J Clin Invest. 1993 Apr;91(4):1582-9.

2.

Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.

Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA, Singel DJ, Loscalzo J.

Arterioscler Thromb. 1993 Jun;13(6):791-9.

3.
4.

Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.

Golino P, Cappelli-Bigazzi M, Ambrosio G, Ragni M, Russolillo E, Condorelli M, Chiariello M.

Circ Res. 1992 Dec;71(6):1447-56.

5.

Nitric oxide and S-nitroso-L-cysteine as endothelium-derived relaxing factors from acetylcholine in cerebral vessels in cats.

Kukreja RC, Wei EP, Kontos HA, Bates JN.

Stroke. 1993 Dec;24(12):2010-4; discussion 2014-5.

6.

Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide.

Marks DS, Vita JA, Folts JD, Keaney JF Jr, Welch GN, Loscalzo J.

J Clin Invest. 1995 Dec;96(6):2630-8.

7.

S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat.

Tsikas D, Sandmann J, Luessen P, Savva A, Rossa S, Stichtenoth DO, Frölich JC.

Biochim Biophys Acta. 2001 Apr 7;1546(2):422-34.

PMID:
11295447
8.

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.

Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J.

Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7674-7.

9.

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

Scharfstein JS, Keaney JF Jr, Slivka A, Welch GN, Vita JA, Stamler JS, Loscalzo J.

J Clin Invest. 1994 Oct;94(4):1432-9.

10.

Smooth muscle relaxing effects of NO, nitrosothiols and a nerve-induced relaxing factor released in guinea-pig colon.

Iversen HH, Gustafsson LE, Leone AM, Wiklund NP.

Br J Pharmacol. 1994 Dec;113(4):1088-92.

11.

Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.

Cappelli-Bigazzi M, Battaglia C, Pannain S, Chiariello M, Ambrosio G.

J Mol Cell Cardiol. 1997 Mar;29(3):871-9.

PMID:
9152848
12.

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.

Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG.

Nature. 1990 May 10;345(6271):161-3.

PMID:
2110626
14.
15.

Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin.

Sellke FW, Myers PR, Bates JN, Harrison DG.

Am J Physiol. 1990 Feb;258(2 Pt 2):H515-20.

PMID:
2106798
16.
17.

Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.

Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ.

J Pharmacol Exp Ther. 1984 Jan;228(1):33-42.

PMID:
6319670
18.
19.
20.

EDRF: nitrosylated compound or authentic nitric oxide.

Bates JN, Harrison DG, Myers PR, Minor RL.

Basic Res Cardiol. 1991;86 Suppl 2:17-26.

PMID:
1953608

Supplemental Content

Support Center